NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients.
J Neurooncol
; 137(1): 39-47, 2018 Mar.
Article
in En
| MEDLINE
| ID: mdl-29404979
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Brain Neoplasms
/
Carmustine
/
Antineoplastic Agents, Alkylating
/
Dose Fractionation, Radiation
/
Glioma
Type of study:
Clinical_trials
Limits:
Adolescent
/
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Neurooncol
Year:
2018
Document type:
Article
Affiliation country:
Estados Unidos
Country of publication:
Estados Unidos